Trial Profile
Peking and Rotterdam on Mission to Reduce Coronary Artery Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms PROMISS
- 06 Aug 2012 New trial record